Jelena Veličković

Jelena Veličković

Auto-generated profile, based on publicly available information

Jelena Veličković

Polyclinic CITILAB, 11000 Belgrade, Serbia

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2022 in Animals
Verified
Journal Article
Open access
PDF file
VBVanja Bugarski-Stanojevic
Vanja Bugarski-Stanojevic
GSGorana Stamenkovic
Gorana Stamenkovic
VJVida Jojic
Vida Jojic
NĆNada Ćosić
Nada Ćosić
DĆDuško Ćirović
Duško Ćirović
ISIvo Savić
Ivo Savić
We explored the cryptic speciation of the Nannospalax leucodon species complex, characterised by intense karyotype evolution and reduced phenotypic variability that has produced different lineages, out of which 25 are described as chromosomal forms (CFs), so many cryptic species remain unnoticed. Although some of them should be classified as threatened, they lack the official nomenclature necessary to be involved in conservation strategies. Reproductive isolation between seven CFs has previously been demonstrated. To investigate the amount and dynamics of genetic discrepancy that follows chromosomal changes, infer speciation levels, and obtain phylogenetic patterns, we analysed mitochondrial 16S rRNA and MT-CYTB nucleotide polymorphism among 17 CFs—the highest number studied so far. Phylogenetic trees delineated 11 CFs as separate clades. Evolutionary divergence values overlapped with acknowledged higher taxonomic categories, or sometimes exceeded them. The fact that CFs with higher 2n are evolutionary older corresponds to the fusion hypothesis of Nannospalax karyotype evolution. To participate in conservation strategies, N. leucodon classification should follow the biological species concept, and proposed cryptic species should be formally named, despite a lack of classical morphometric discrepancy. We draw attention towards the syrmiensis and montanosyrmiensis CFs, estimated to be endangered/critically endangered, and emphasise the need for detailed monitoring and population survey for other cryptic species.

6 April 2020 in Mammalian Biology
Verified
Journal Article
Closed access
PDF file
VBVanja Bugarski-Stanojevic
Vanja Bugarski-Stanojevic
GSGorana Stamenković
Gorana Stamenković
DĆDuško Ćirović
Duško Ćirović
DĆDanica Ćirić
Danica Ćirić
OSOliver Stojković
Oliver Stojković
ISIvo Savić
Ivo Savić

11 October 2023 in Neuroscience
Verified
Journal Article
Closed access
EDEleonora Džoljić
Eleonora Džoljić
MMMarija Saric Matutinovic
Marija Saric Matutinovic
OSOliver Stojković
Oliver Stojković
JVJelena Veličković
Jelena Veličković
NMNeda Milinkovic
Neda Milinkovic
SISvetlana Ignjatović
Svetlana Ignjatović

26 September 2019 in Autoimmunity
Verified
Journal Article
Closed access
JVJelena Velickovic
Jelena Velickovic
FSFatma Silan
Fatma Silan
FBFirdevs Dincsoy Bir
Firdevs Dincsoy Bir
CSCoskun Silan
Coskun Silan
BABurcu Albuz
Burcu Albuz
OOOzturk Ozdemir
Ozturk Ozdemir
Blau syndrome is an autosomal dominant rare disease caused by mutations in NOD2 gene. Less than 200 patients published with Blau Syndrome Worldwide. We reported a 41-year old female Turkish patient diagnosed as Blau syndrome. Granulomatous dermatitis and severe headache, as well as recurrent chest and pelvic pain have been present since she was 8 years old. Arthritis started when she was teenage, hypertension diagnosed when she was 20 and other symptoms also occurred during the lifetime (severe preeclampsia, ischemic stroke, recurrent hemiparesis, recurrent-transient-vision-loss and renal-artery-stenosis). Genomic DNA was isolated from peripheral blood and 12 genes sequenced in Autoinflammatory panel on IonTorrent-S5-NGS platform with Parseq-VariFind™AIPassay. NGS analysis showed 107 variants in in the index case, mainly benign with no strong association with Blau syndrome. Additionally, we identified one very rare missense mutation in NOD2 gene (c2803G>A, p.Val935Met) and in silico assessment of the mutation indicated possible pathogenic significance and strong association with Blau syndrome. In addition, we analyzed family members of the index case and identified the same mutation in NOD2 gene. The segregation analysis shows the presence of the same mutant allele in NOD2 gene in the index case affected sister, as well as in her son with arthralgia, while in her non affecter brother we didn’t detect the Val935Met mutation in NOD2 gene. Blau Syndrome is known as a very rare disease, mainly caused by mutations in NOD2 gene. Missense mutation diagnosed in our case could be responsible for the phenotype of the index case. Our results indicate the importance of NGS testing and its major role in the detection of rare mutations that may responsible for the onset of autoinflammatory disorders.

1 September 2019 in Blood Coagulation & Fibrinolysis
Verified
Journal Article
Closed access
JVJelena Velickovic
Jelena Velickovic
KZKatarina Zeljic
Katarina Zeljic
JTJelena Todorovic
Jelena Todorovic
GSGorana Stamenkovic
Gorana Stamenkovic
OSOliver Stojkovic
Oliver Stojkovic
A numerous factor can cause infertility, but around one of four reproductive failure cases remain unexplained and diagnosed as idiopathic infertility. In the past few decades, analysis of gene polymorphisms takes a significant place in pathogenesis of infertility. The aim of this study was to evaluate the possible role of hemostasis-related gene polymorphisms in unexplained infertility. The study includes 117 female patients with idiopathic infertility and 130 fertile women with at least one born child. Eight polymorphisms important for hemostasis (ITGB3 1565T>C, FV 1691G>A, FII 20210G>A, MTHFR 677C>T and 1298A>C, ATIII 786G>A, PAI-14G/5G and ACE I/D) were genotyped by real-time PCR system. The frequencies of alleles and genotypes of examined polymorphisms were analyzed in SPSS statistical program, whereas gene interactions were identified using the GMDR software. Examination of etiological factors has shown that family history is a significant factor in assessing individual risk for infertility. The alleles and genotypes frequency of FV 1691G>A and FII 20210G>A polymorphisms were statistically different between control and patient group leading to a greater risk for infertility. The analysis of epistatic relationship between examined hemostasis-related gene polymorphisms identified more complex high-risk genotypes associated with infertility. Our results suggest that positive family history could be important predictive factor for fertility problems, pointing to the potential hereditary basis of this condition. Polymorphisms FVL and FII prothrombin are independent risk factors for idiopathic infertility, whereas multilocus interactions approach should be taken into consideration for the future research.